On #NationalSeniorCitizensDay, we recognize the wisdom and contributions of older adults. Managing #bloodpressure is an important part of healthy aging and can help protect long-term heart, kidney, and brain health. Encourage an older loved one to know their numbers. #HeartHealth #CardioSky

Healthy habits support #bloodpressure, yet for many people it stays high even with lifestyle changes and standard medicines. Dysregulated #aldosterone drives ~30% of #hypertension. This #NationalWellnessMonth, know your numbers and understand your drivers.

#DYK extreme heat can affect the body’s fluid balance, electrolytes, and #bloodpressure? Aldosterone, a hormone produced by the adrenal glands, helps regulate sodium and water balance, which is essential for maintaining blood volume and blood pressure. ☀️

Every hour, high #bloodpressure contributes to 1,000+ deaths from stroke and heart attack globally. Summer heat adds strain, so try to prioritize hydration, avoid prolonged heat exposure, & consult your #HCP on #hypertension management as temperatures climb. #CRMS #PublicHealth #CardioSky

Research links chronic stress, anxiety, and depression to ⬆️ #hypertension risk in #BIPOC populations. Mental & emotional health are part of the cardiovascular risk conversation. Mineralys is committed to research that reflects the diversity of populations most affected by #bloodpressure disparities.

A new literature review adds to the growing evidence linking dysregulated #aldosterone to #hypertension and to cardiovascular, kidney, and metabolic disease. At Mineralys, we’re targeting it directly. #CRMS #CardioSky #NephSky

#HighBloodPressure isn’t just a later-life concern. For U.S. adults 18-39, #hypertension is nearly twice as common in men than women. Know your numbers this #MensHealthWeek. #MensHealthMonth

We presented a new post hoc analysis on the effect of lorundrostat on #heartfailure risk biomarkers from participants in our pivotal Launch-HTN & Advance-HTN trials during a late-breaking poster presentation at #ENDO2026. Read more: ir.mineralystx.com/news-events/... #CVD #Hypertension #Cardiosky

#DYK brain & cardiovascular health are linked? ~20% of the body’s blood supply flows to the brain. Chronic #HighBloodPressure can damage blood vessels and, over time, may contribute to cognitive decline.

A new post hoc analysis of proteomic data from the Launch-HTN and Advance-HTN trials of lorundrostat will be featured in a late-breaking poster presentation on June 14 at #ENDO2026. Read more: ir.mineralystx.com/news-events/... #Hypertension #LateBreakingData

1 in 2 men in the U.S. are living with #hypertension. This Men's Health Month, Mineralys is focused on advancing cardiovascular research and the science of blood pressure control. #MensHealthMonth #HeartHealth #BloodPressureAwareness #CardioSky

We shared new data from a post hoc analysis of our Ph 3 Launch-HTN trial during an oral presentation at #ESH2026: in participants with #hypertension and #CKD, lorundrostat significantly reduced #bloodpressure, and among the subset with CKD and baseline albuminuria, UACR.

The latest AHA/ACC guidelines from 2025 lowered the #hypertension treatment threshold. Earlier intervention saves lives, yet <50% of adults w/ high blood pressure have it under control, and the burden falls hardest on Black adults, women & the elderly. Know your numbers this #HighBloodPressureMonth.

New data from our Phase 3 Launch-HTN trial of lorundrostat in participants with hypertension and CKD will be featured in an oral presentation on Saturday, May 30th at #ESH2026 in Gdańsk, Poland. Read more: ir.mineralystx.com/news-events/... #Hypertension #CKD #ClinicalData #CardioSky #NephSky

Today is #WorldHypertensionDay, a global reminder that hypertension control takes all of us. BP screenings and lifestyle education reduce the risk of stroke, heart disease, and kidney disease. Know your numbers. Protect your future. #WHD2026 #GlobalHealth #Hypertension #CardioSky

It’s #NationalWomensHealthWeek & #WomensCheckupDay. Women, especially those with obesity or diabetes, face a disproportionate burden of treatment-resistant #hypertension, and #aldosterone is frequently an overlooked driver. Get your #bloodpressure checked. Ask what's behind it. #CardioSky

May is #HighBloodPressureMonth. Nearly half of U.S. adults have high blood pressure and many don't know it. Many sufferers have no symptoms. The first step: get your blood pressure checked. #Hypertension #HeartHealth #CardioSky

#CKD disproportionately affects racial and ethnic minority populations and is often underdiagnosed, with many individuals unaware of their disease. #MinorityHealthAwarenessMonth

It’s #AdrenalAwarenessMonth. Aldosterone, produced in the adrenal glands, regulates #bloodpressure. Some people with #hypertension have dysregulated #aldosterone - a key driver of uncontrolled or resistant hypertension & #CRMS. At Mineralys, we're targeting it directly. #CardioSky #NephSky

We’re proud to share a major milestone: our publication in Clinical and Translational Science has been named a Top 10 most-cited paper of 2024. This recognition reflects the impact of our work in advancing translational science. 🚀 #Hypertension #ClinicalResearch

This #MinorityHealthMonth, we recognize #hypertension as a critical public health issue affecting millions - but not equally. Despite treatments, racial & ethic groups have undiagnosed or poorly controlled hypertension, leading to considerable health risks and economic burden.

If you’re attending #ACC26, stop by & connect with our Med Affairs team to learn more about our focus on aldosterone biology in #hypertension and CRM diseases. 📍Booth #1150 We hope to see you! #HighBloodPressure #CKD #NOLA

#DYK that both #hypertension and reduced kidney function are among risk factors for cardio-renal-metabolic (CRM) syndrome - a disorder attributable to connections among heart disease, kidney disease, diabetes, & obesity.

We are thrilled to announce the appointment of Jeffrey A. Munsie as Mineralys’ Chief Legal Officer. Read more: ir.mineralystx.com/news-events/... #Hypertension $MLYS

Today we reported financial results for the fourth quarter and full year ending December 31, 2025, and provided a corporate update. Learn more: ir.mineralystx.com/news-events/... #Hypertension #ChronicKidneyDisease $MLYS

The U.S. FDA has accepted our NDA for lorundrostat for the treatment of adult patients with other antihypertensive drugs and set a PDUFA date of Dec. 22. Also announced were topline results from the P2 Explore-OSA exploratory trial. Details here: ir.mineralystx.com/news-events/... #Hypertension

As American Heart Month wraps up, it’s worth remembering that heart health is bigger than the heart alone. Mineralys Therapeutics is taking a targeted approach to hypertension and cardio-renal-metabolic disease by addressing a key driver, aldosterone. #CRM #HeartHealth #HeartMonth

In February we honor #HeartMonth, as well as #CardiovascularProfessionalsWeek. Mineralys celebrates the dedicated individuals working tirelessly on the prevention, diagnosis, treatment and rehabilitation of heart and vascular diseases.

February is American #HeartMonth ❤️ Despite the availability of effective therapies for #hypertension, treatment and control rates have stalled and related CV death rates in the U.S. have nearly doubled in 20 years. At Mineralys, we’re advancing science to change this trajectory. #KnowYourNumbers

Our CEO spoke with @firstwordgroup.com about how Mineralys is reviving innovation in #hypertension by targeting aldosterone, what differentiates the company’s approach, and where lorundrostat could play a role in cardiorenal & metabolic disease. Read the interview: firstwordpharma.com/story/7067623